BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Avion and Acella Pharmaceuticals Provide Statement Related to Avondale Drug Pricing News

  Avion and their partner company, Acella Pharma, recently responded to the recent news surrounding the Avondale Pharma product Niacor, a prescription version of niacin.

  December 13, 2017

   · 

  2 min read
• BioCapital

  IBBR Awarded NIH Grant to Investigate Body’s T-Cell Mechanism of Attack

  A new research initiative by the University of Maryland’s IBBR and the University of Pittsburgh could finally uncover how T-cells--the “killer cells” that defend the body from microbes--are alerted to hazardous invaders in the body.

  December 13, 2017

   · 

  3 min read
• BioForest

  Cascadian Therapeutics Added to the Nasdaq Biotechnology Index

  This will become effective prior to U.S. market open on Monday, December 18, 2017.

  December 13, 2017

   · 

  1 min read
• Drug Development

  Iovance Biotherapeutics Expands Pipeline of TIL Therapies Into Lung Cancer

  The company also announced that a Phase 2 study in PD-1/PDL-1 naïve NSCLC patients will initiate in the first half of 2018.

  December 13, 2017

   · 

  5 min read
• Business

  Telix Pharmaceuticals and JFE Announce Japanese Radiopharmaceutical Manufacturing Partnership

  JFE is an engineering and manufacturing company with extensive expertise in the installation of cyclotron infrastructure and radiopharmaceutical manufacturing in Japan.

  December 13, 2017

   · 

  3 min read
• Pharm Country

  Brainsway Raises $8.5M From Leading Israeli Investors

  The financing was led by the Phoenix Group (Israel), which will own more than 7% in the Company.

  December 13, 2017

   · 

  3 min read
• Bio NC

  Fennec Announces Closing of Public Offering

  The total gross proceeds from the offering (before deducting the underwriting discounts and offering expenses) was $21,153,270.

  December 13, 2017

   · 

  3 min read
• Biotech Bay

  NEOFECT’s New Robotic Glove Helps Paralyzed Patients Regain Movement

  The NeoMano, a new wearable robotic glove, will debut at CES and launch on Kickstarter in the early half of 2018, enabling people with paralysis to regain the ability to perform daily tasks and the independence that goes with it.

  December 13, 2017

   · 

  4 min read
• Titan Medical Strengthens Patent Portfolio With Issuance of Two Canadian Patents and Allowance of a Japanese Patent

  In addition to the issuance of the Canadian patents, the Company has received an official Decision to Grant from the Japan Patent Office regarding a pending Japanese patent application.

  December 13, 2017

   · 

  4 min read
• BELLUS Health Closes $20M Common Share Financing

  The majority of the Offering was subscribed to by healthcare specialized institutional investors and also included the participation by members of the senior management team and board of directors of the Company.

  December 13, 2017

   · 

  8 min read